- Single-centre prospective observational study of intraoperative data from 20 adult female patients undergoing breast surgery during stable propofol-remifentanil anaesthesia.
- Lidocaine was given as a 1.5 mg/kg i.v. bolus over 10 min, followed by a 30 min infusion at 1.5 mg/kg/h, and EEG, BIS, SEF95 and SPI were tracked.
- Delta-band EEG activity increased and beta-band activity decreased 4 to 6 min after the bolus, while BIS and SEF95 did not change significantly at that time.
- BIS, SEF95 and SPI decreased later in the infusion phase, and the authors conclude that EEG changes precede BIS, SEF95 and SPI changes, consistent with an antinociceptive contribution.
Pharmacology
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- A prospective multicentre cross-sectional service evaluation across 23 UK NHS hospitals included 233 rapid sequence inductions for emergency intubation outside theatres, excluding 17 cardiac arrest cases.
- Propofol was used in 63% and fentanyl in 74%, with propofol plus fentanyl the most common combination (42%) and a median propofol dose of 1.4 mg/kg.
- Severe hypotension occurred in 24/219 (11%) and severe hypoxia in 14/221 (6%), while post-induction cardiac arrest occurred in 6/233 (3%).
- Of patients without pre-emptive vasopressors, 40/105 (38%) later needed vasopressors, and the authors call for standardised protocols for induction drug choice, dose and vasopressor use.
- Prospective observational cohort of 547 adults (282 received i.v. methadone, 265 did not) undergoing elective surgery under general anaesthesia.
- Single-dose i.v. methadone at induction was compared with no methadone, typically fentanyl, with QTcF measured before and for 1 h afterward.
- New QTcF >500 ms occurred in 2.5% of methadone patients vs 8.3% of controls (RR 0.34, 95% CI 0.16-0.75, P=0.009).
- The authors concluded a single induction dose of methadone did not prolong QTcF, with no clinically meaningful effect, and dose did not correlate with QTcF change.
- Retrospective multicentre cohort using a federated health record network, with propensity-matched adults (15,730 total, 7865 per group) undergoing upper GI endoscopy under general anaesthesia after rocuronium.
- Compared reversal of neuromuscular block with sugammadex versus neostigmine, with failure of tracheal extubation (ventilator dependence or reintubation within 30 days) as the primary outcome.
- Extubation failure was 3.88% with sugammadex versus 5.79% with neostigmine (risk ratio 1.49, 95% CI 1.30-1.72, p<0.0001).
- Sugammadex was also associated with less lung atelectasis and unplanned ICU admission, and the authors report similar findings in patients without chronic pulmonary disease.
- Retrospective single-center cohort of 30 critically ill adults with acute or acute-on-chronic liver failure who received MARS and piperacillin-tazobactam, with 121 measurements across 77 sessions.
- Piperacillin concentrations were measured immediately before and after each 8-hour MARS session, and the abstract describes no separate comparator group.
- The mean relative reduction per session was 34% (±7.9%; p < 0.05), with higher creatinine clearance linked to greater drug loss and higher bilirubin to less.
- The authors report that MARS was associated with about a one-third reduction per session and support systematic drug monitoring and individualized dosing, though 31.6% of post-session levels fell below 80 mg/L.
- Prospective study of 30 adults under general anesthesia with propofol and remifentanil target-controlled infusion, monitored concurrently with ANI and NOL.
- The two nociception monitors were compared by sorting readings into insufficient, adequate, or excessive analgesia using manufacturer thresholds.
- Across more than 38 hours of paired recordings, the monitors agreed 43.7% of the time, with 1-category and 2-category disagreements in 37.1% and 8.7% of recordings.
- Excessive analgesia was recorded for 37.6% (ANI) and 38.1% (NOL) of surgical time, and the authors suggest a multimodal monitoring strategy may help.